Invitrocue
Healthcare Services · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Hildegardstraße 9, Munich, Bavaria, 8053...Phone Number
+49 89998209480Website
www.invitrocue.comRevenue
<$5 MillionStock Symbol
IVQIndustry
About Invitrocue
Invitrocue is a leading provider of personalized oncology and bio-analytics solutions, specializing in personalized cancer testing, in vitro cell-based testing technologies, and image analytics software. The company has developed a unique 3D cell-based scaffolding technology that allows for the culture of patient-derived cancer cells to support clinical decision-making. Their Onco-PDO test utilizes patients' own cancer cells to identify the most effective treatment options by testing them against a panel of approved chemotherapy drugs. Invitrocue serves patients, healthcare providers, scientists, and researchers, focusing on personalized treatment and safety and efficacy testing.Explore more
Invitrocue Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Invitrocue
Compare insights from companies similar to Invitrocue, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Invitrocue Tech Stack
A closer look at the technologies used by Invitrocue
See more technologies
Top Healthcare Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Invitrocue
Sign Up For FreeTo access detailed company insights
Invitrocue is a leading provider of personalized oncology and bio-analytics solutions, specializing in personalized cancer testing, in vitro cell-based testing technologies, and image analytics software. The company has developed a unique 3D cell-based scaffolding technology that allows for the culture of patient-derived cancer cells to support cli... Read More
